Format

Send to

Choose Destination
Bone Marrow Transplant. 2019 Feb 26. doi: 10.1038/s41409-019-0493-5. [Epub ahead of print]

Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival.

Author information

1
Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
2
Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
3
Department of Statistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.
4
University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
5
Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA. sungchoi@med.umich.edu.
PMID:
30809038
DOI:
10.1038/s41409-019-0493-5

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center